Oncotelic Therapeutics, Inc. Business Combination, Contingent Consideration, Liability
Oncotelic Therapeutics, Inc. (OTLC) had Business Combination, Contingent Consideration, Liability of $2.60 million as of 2023-12-31, per its 10-K filed 2024-04-12.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2024-04-12
- 2023-12-31: Business Combination, Contingent Consideration, Liability $2.60M.
- 2022-12-31: Business Combination, Contingent Consideration, Liability $2.60M.
- 2022-03-31: Business Combination, Contingent Consideration, Liability $2.60M.
- 2021-12-31: Business Combination, Contingent Consideration, Liability $2.60M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2023-12-31 | $2.60M 10-K · filed 2024-04-12 |
| 2022-12-31 | $2.60M 10-K/A · filed 2023-04-20 |
| 2022-03-31 | $2.60M 10-Q · filed 2022-05-23 |
| 2021-12-31 | $2.60M 10-K · filed 2022-04-15 |
| 2021-09-30 | $2.60M 10-Q · filed 2021-11-22 |
| 2021-06-30 | $2.60M 10-Q · filed 2021-08-20 |
| 2021-03-31 | $2.60M 10-Q · filed 2021-05-24 |
| 2020-12-31 | $2.60M 10-K · filed 2021-04-15 |
| 2020-09-30 | $2.60M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $2.60M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $2.60M 10-Q · filed 2020-06-29 |
| 2019-12-31 | $2.60M 10-K · filed 2020-05-14 |